Asters advising on creation of the second-largest pharmaceutical company in the world
Asters provided legal advise on Ukrainian merger control law issues, including representation in in-depth merger control investigation by the Antimonopoly Committee of Ukraine (AMCU) and obtaining merger clearance in connection with a merger of two global pharmaceutical companies – Schering-Plough Corporation and Merck & Co., Inc The combined company will use the trade name Merck in the USA and Canada, and MSD elsewhere.
The combined company is a global health care leader with a diversified portfolio of prescription medicines, vaccines, and consumer health products, as well as animal health products.
The filing with the AMCU was handled by associates Tatiana Buchko and Marina Kovalko under the supervision of partner Igor Svechkar.